Showing results (51-60 of 388) with videos related to
Sort By:
Pageof 39
Drug Design, Development and Therapy|April 20, 2023
Berberine Alleviates Acute Lung Injury in Septic Mice by Modulating Treg/Th17 Homeostasis and Downregulating NF-κB SignalingLongwang Chen, Xinyong Liu, Xuetao Wang, et al.European Journal of Medicinal Chemistry|March 14, 2015
Discovery of HCV NS5B thumb site I inhibitors: core-refining from benzimidazole to indole scaffoldFabao Zhao, Na Liu, Peng Zhan, et al.Future Medicinal Chemistry|June 26, 2014
Conformational restriction: an effective tactic in 'follow-on'-based drug discoveryZengjun Fang, Yu'ning Song, Peng Zhan, et al.Medicinal Research Reviews|July 28, 2025
Recent Progress in the Discovery of Anti-Mpox AgentsLe Wang, Tao Zhang, Na Wang, et al.Frontiers in Medicine|March 9, 2026
The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol ratio as a novel composite biomarker for predicting 28-day all-cause mortality in sepsis: a retrospective cohort studyYidong Chen, Wenlin Xie, Liangmei Zhu, et al.Expert Opinion on Therapeutic Patents|September 29, 2015
Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419Qing Meng, Na Liu, Boshi Huang, et al.Current Medicinal Chemistry|September 15, 2009
Design strategies of novel NNRTIs to overcome drug resistancePeng Zhan, Xinyong Liu, Zhenyu Li, et al.European Journal of Medicinal Chemistry|August 16, 2015
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motifWenxin Li, Xiao Li, Erik De Clercq, et al.Current Medicinal Chemistry|December 15, 2010
Recent advances in DAPYs and related analogues as HIV-1 NNRTIsXuwang Chen, Peng Zhan, Dongyue Li, et al.European Journal of Medicinal Chemistry|September 10, 2014
Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806Tao Liu, Boshi Huang, Peng Zhan, et al.Pageof 39